[1] |
熊若言, 陈燕, 赵志琪, 等. 慢性阻塞性肺疾病合并吸入糖皮质激素相关肺结核三例. 中国感染控制杂志, 2022, 21(10):1026-1030. doi:10.12138/j.issn.1671-9638.20222559.
|
[2] |
陈燕玲, 吴迪, 陈秀平, 等. 肺结核及并发肺外结核患者淋巴细胞亚群变化的研究及其临床意义. 结核与肺部疾病杂志, 2024, 5(4): 294-304. doi:10.19983/j.issn.2096-8493.2024042.
|
[3] |
Pando-Sandoval A, Ruano-Ravina A, Candal-Pedreira C, et al. Risk factors for chronic obstructive pulmonary disease in never-smokers: A systematic review. Clin Respir J, 2022, 16(4):261-275. doi:10.1111/crj.13479.
pmid: 35142054
|
[4] |
Jindal SK. Is pulmonary tuberculosis a true risk-factor for chronic obstructive pulmonary disease? Indian J Tuberc, 2022, 69(2):131-133. doi:10.1016/j.ijtb.2021.09.013.
pmid: 35379391
|
[5] |
周伊南, 朱惠莉. 慢性阻塞性肺疾病合并肺结核的研究进展. 结核与肺部疾病杂志, 2022, 3(4):338-342. doi:10.19983/j.issn.2096-8493.20220013.
|
[6] |
世界中医药学会联合会内科专业委员会. 慢性阻塞性肺疾病中西医结合诊疗指南(2022版). 中国循证医学杂志, 2023, 23(10):1117-1128. doi:10.7507/1672-2531.202304016.
|
[7] |
杨春龙, 周林, 陈明亭. 《病原学检测阴性肺结核诊断流程(T/CHATA 008—2020)》解读. 中国防痨杂志, 2021, 43(11): 1116-1119. doi:10.3969/j.issn.1000-6621.2021.11.003.
|
[8] |
徐鹏, 殷应传, 张国柱. 基于倾向性评分匹配的老年患者低血糖危险因素分析. 中国医院药学杂志, 2021, 41(8):824-827,832. doi:10.13286/j.1001-5213.2021.08.11.
|
[9] |
Ye X, Su X, Shi J, et al. Incidence, causes, and risk factors for unplanned readmission in patients admitted with pulmonary tuberculosis in China. J Infect Dev Ctries, 2023, 17(7): 1007-1013. doi:10.3855/jidc.17190.
|
[10] |
任家辉, 乔宇超, 任浩, 等. 基于倾向性评分匹配的慢性阻塞性肺疾病影响因素研究. 中华疾病控制杂志, 2022, 26(7): 857-861. doi:10.16462/j.cnki.zhjbkz.2022.07.019.
|
[11] |
Tao NN, Li YF, Song WM, et al. Risk factors for drug-resistant tuberculosis, the association between comorbidity status and drug-resistant patterns: a retrospective study of previously treated pulmonary tuberculosis in Shandong, China, during 2004—2019. BMJ Open, 2021, 11(6): e044349. doi:10.1136/bmjopen-2020-044349.
|
[12] |
Knox-Brown B, Patel J, Potts J, et al. Small airways obstruction and its risk factors in the Burden of Obstructive Lung Disease (BOLD) study: a multinational cross-sectional study. Lancet Glob Health, 2023, 11(1):e69-e82. doi:10.1016/S2214-109X(22)00456-9.
pmid: 36521955
|
[13] |
王明航, 蔡坤坤, 施丁莉, 等. 基于回归分析法建立慢性阻塞性肺疾病急性加重风险预测模型与验证. 中华危重病急救医学, 2021, 33(1):64-68. doi:10.3760/cma.j.cn121430-20200720-00534.
|
[14] |
Kamenar K, Hossen S, Gupte AN, et al. Previous tuberculosis disease as a risk factor for chronic obstructive pulmonary disease: a cross-sectional analysis of multicountry, population-based studies. Thorax, 2022, 77(11):1088-1097. doi:10.1136/thoraxjnl-2020-216500.
|
[15] |
吕和, 王政, 王婷, 等. 非活动性肺结核并发慢性阻塞性肺疾病患者营养状况及营养风险分析. 中国防痨杂志, 2020, 42(12):1310-1312. doi:10.3969/j.issn.1000-6621.2020.12.011.
|
[16] |
Tan Y, Deng Y, Yan X, et al. Nontuberculous mycobacterial pulmonary disease and associated risk factors in China: A prospective surveillance study. J Infect, 2021, 83(1): 46-53. doi:10.1016/j.jinf.2021.05.019.
pmid: 34048821
|
[17] |
Zavala MJ, Becker GL, Blount RJ. Interrelationships between tuberculosis and chronic obstructive pulmonary disease. Curr Opin Pulm Med, 2023, 29(2):104-111. doi:10.1097/MCP.0000000000000938.
pmid: 36647566
|
[18] |
贾钦尧, 宋珊, 程耀, 等. 慢性阻塞性肺疾病患者合并肺结核的影响因素分析及其列线图预测模型的建立. 中国感染与化疗杂志, 2023, 23(1):47-52. doi:10.16718/j.1009-7708.2023.01.008.
|
[19] |
Park HY, Kang D, Shin SH, et al. Pulmonary Tuberculosis and the Incidence of Lung Cancer among Patients with Chronic Obstructive Pulmonary Disease. Ann Am Thorac Soc, 2022, 19(4): 640-648. doi:10.1513/AnnalsATS.202010-1240OC.
|
[20] |
Lin Q, Chen J, Yu T, et al. Risk factors for the recurrence in pulmonary tuberculosis patients with massive hemoptysis. Clin Respir J, 2023, 17(7):663-671. doi:10.1111/crj.13653.
pmid: 37406999
|